BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28533443)

  • 1. FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.
    Csincsi ÁI; Szabó Z; Bánlaki Z; Uzonyi B; Cserhalmi M; Kárpáti É; Tortajada A; Caesar JJE; Prohászka Z; Jokiranta TS; Lea SM; Rodríguez de Córdoba S; Józsi M
    J Immunol; 2017 Jul; 199(1):292-303. PubMed ID: 28533443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization.
    Kárpáti É; Papp A; Schneider AE; Hajnal D; Cserhalmi M; Csincsi ÁI; Uzonyi B; Józsi M
    Front Immunol; 2020; 11():1297. PubMed ID: 32765490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
    J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C; Kingzette M; Gewurz H
    J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Murine Factor H-Related Protein FHR-B Promotes Complement Activation.
    Cserhalmi M; Csincsi ÁI; Mezei Z; Kopp A; Hebecker M; Uzonyi B; Józsi M
    Front Immunol; 2017; 8():1145. PubMed ID: 28974948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Factor H related protein 1 and immune inflammatory disorders.
    Li X; Zong J; Si S
    Mol Immunol; 2022 May; 145():43-49. PubMed ID: 35279539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.
    Papp A; Papp K; Uzonyi B; Cserhalmi M; Csincsi ÁI; Szabó Z; Bánlaki Z; Ermert D; Prohászka Z; Erdei A; Ferreira VP; Blom AM; Józsi M
    Front Immunol; 2022; 13():845953. PubMed ID: 35392081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation.
    Csincsi ÁI; Kopp A; Zöldi M; Bánlaki Z; Uzonyi B; Hebecker M; Caesar JJ; Pickering MC; Daigo K; Hamakubo T; Lea SM; Goicoechea de Jorge E; Józsi M
    J Immunol; 2015 May; 194(10):4963-73. PubMed ID: 25855355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
    Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
    Front Immunol; 2021; 12():615748. PubMed ID: 33732239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
    Hebecker M; Alba-Domínguez M; Roumenina LT; Reuter S; Hyvärinen S; Dragon-Durey MA; Jokiranta TS; Sánchez-Corral P; Józsi M
    J Immunol; 2013 Jul; 191(2):912-21. PubMed ID: 23772024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.
    Kopp A; Strobel S; Tortajada A; Rodríguez de Córdoba S; Sánchez-Corral P; Prohászka Z; López-Trascasa M; Józsi M
    J Immunol; 2012 Aug; 189(4):1858-67. PubMed ID: 22786770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and pentraxin-3 binding of factor H-like protein 1 differs from complement factor H: implications for retinal inflammation.
    Swinkels M; Zhang JH; Tilakaratna V; Black G; Perveen R; McHarg S; Inforzato A; Day AJ; Clark SJ
    Sci Rep; 2018 Jan; 8(1):1643. PubMed ID: 29374201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.
    Márquez-Tirado B; Gutiérrez-Tenorio J; Tortajada A; Lucientes Continente L; Caravaca-Fontán F; Malik TH; Roldán Montero R; Elías S; Saiz Gonzalez A; Fernández-Juarez G; Sánchez-Corral P; Pickering MC; Praga M; Rodríguez de Córdoba S; Goicoechea de Jorge E
    J Am Soc Nephrol; 2022 Jun; 33(6):1137-1153. PubMed ID: 35545301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of classical C5 convertase in the complement system by factor H.
    Ito S; Tamura N
    Immunology; 1983 Dec; 50(4):631-5. PubMed ID: 6228516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.
    Okemefuna AI; Nan R; Miller A; Gor J; Perkins SJ
    J Biol Chem; 2010 Jan; 285(2):1053-65. PubMed ID: 19850925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
    Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
    Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement factor H-ligand interactions: self-association, multivalency and dissociation constants.
    Perkins SJ; Nan R; Li K; Khan S; Miller A
    Immunobiology; 2012 Feb; 217(2):281-97. PubMed ID: 22137027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation.
    Deban L; Jarva H; Lehtinen MJ; Bottazzi B; Bastone A; Doni A; Jokiranta TS; Mantovani A; Meri S
    J Immunol; 2008 Dec; 181(12):8433-40. PubMed ID: 19050261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.
    Jarva H; Jokiranta TS; Hellwage J; Zipfel PF; Meri S
    J Immunol; 1999 Oct; 163(7):3957-62. PubMed ID: 10490997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.